European Commission approves Fuzeon following FDA approval--first HIV-fusion inhibitor in fight against HIV.  [electronic resource] 

 -  Infection  Aug 2003 
 - 7-8 p.  digital 
<br/><br/> Publication Type: News 
<br/><br/><label>ISSN: </label>0300-8126 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Clinical Trials as Topic<br/>Drug Approval<br/>Enfuvirtide<br/>European Union<br/>Female<br/>HIV Envelope Protein gp41--administration & dosage<br/>HIV Fusion Inhibitors--administration & dosage<br/>HIV Infections--diagnosis<br/>Humans<br/>Male<br/>Peptide Fragments--administration & dosage<br/>Prognosis<br/>Treatment Outcome<br/>United States<br/>United States Food and Drug Administration